Skip to content

Study · Not a test of the peptide alone · 2011

1 result

NMR structure of human thymosin alpha-1.

Elizondo-Riojas MA, Chamow SM, Tuthill CW, Gorenstein DG, Volk DE

Biochemical and biophysical research communications15 Nov 2011Cited by 18 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin alpha-1.

  1. 01LabNot a test of Thymosin alpha-1 aloneIn vitro (cell-free)Other

    In 40% TFE/60% water, thymosin alpha‑1 adopts a structure with an alpha-helix from residues 14 to 26 and two double beta-turns in the N-terminal twelve residues.

    In plain wordsIn lab tests in a solvent mixture, thymosin alpha‑1 formed a helix in its later part and turns near its start.

    Outcome
    Not applicableNMR structure of thymosin alpha-1 in 40% TFE
    Study

    n: not reported in source

    40% TFE/60% water solution
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    We found that the peptide adopts a structured conformation having two stable regions: an alpha-helix region from residues 14 to 26 and two double β-turns in the N-terminal twelve residues which form a distorted helical structure.
    1 context sentence
    Summary · context
    800 MHz NMR structure of the 28-residue peptide thymosin alpha-1 in 40% TFE/60% water (v/v) has been determined.

    In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.